Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Status:
Completed
Trial end date:
2009-02-24
Target enrollment:
Participant gender:
Summary
RATIONALE: Cyclophosphamide may help control the symptoms of autoimmune enteropathy .
PURPOSE: This phase II trial is studying how well cyclophosphamide works in treating young
patients with severe autoimmune enteropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center